First patient enrolled in a prospective randomized trial with erectile dysfunction using SELUTION SLR
Geneva, Switzerland, September 10, 2022 /PRNewswire/ — An 82-year-old Taiwanese man becomes the first patient enrolled in the first ever erectile dysfunction (ED) randomized clinical trial (RCT) involving SELUTION SLR™, MedAlliance’s new sirolimus-releasing balloon. FIM Perfect Selection (PHYSICAL EDUCATION Rivico rhemostasis debt Also me again Connecticut The ile dysfunction-SELUTION First-In-Man study will include a total … Read more